WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'7101 Infant (under 12 months) mortality rate: 282
GDP / capita (US$): 15'1881 Child (under 5 years) mortality rate: 342

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 34'769  33'765  32'778  31'837  30'962  23'801  17'518  13'653 
Births 1'068  1'052  1'037  1'022  1'008  854  666  545 
Surviving infants 1'039  1'023  1'007  992  977  824  642  518 
Pop. less than 5 years 4'995  4'909  4'824  4'747  4'682  3'865  3'017  2'435 
Pop. less than 15 years 13'785  13'526  13'262  13'006  12'766  10'187  8'036  6'395 
Female 15-49 years 8'640  8'338  8'037  7'748  7'477  5'636  3'846  2'793 

Number of reported case

(Click for retrospective incidence data for Iraq)
Diphtheria 34  10  1'122 
Japanese encephalitis
Measles 1'317  669  15  15  492  726  3'045  26'542 
Mumps 1'295  1'809  1'482  1'944  1'862  18'720 
Pertussis 1'606  2'471  2'314  2'019  2'034  407  122  16'687 
Polio* 56  997 
Rubella 30  22  18  15  1'612 
Rubella (CRS)
Tetanus (neonatal) 10  11  10  11  37  152  891 
Tetanus (total)** 31  34  34  39  25  1'045 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Iraq)
Vaccine year result method % card seen                                                
BCG 2010  90  MICS   70  91  93  99*  69  86  79  95  76 
DTP1 2010  86  MICS   70  84  89  95  97  93  92  91 
DTP3 2010  70  MICS   70  74  78  79  89  84  86  83  13 
HepB_BD          43  43  37  27  79 
HepB3 2010  66  MICS   70  74  78  73  89  84  67 
Hib3          74  78  46 
JapEnc         
MCV          71  77  83  91  89  93  83  35 
MCV2          76  71  82  91  91 
PCV1         
PCV3         
Pol3 2010  76  MICS   70  76  79  79  89  83  86  83  16 
Rota1          60  68  65 
Rota_last          51  52  31 
Rubella1          76  71  82  91 
TT2plus 2010  29  MICS   70  49  59  66  75  69  55  63 
PAB         
VAD1          60  67  17  66  44  49 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Iraq)
BCG 90  90  90  90  93  96  76 
DTP1 82  87  90  86  92  93  36 
DTP3 68  69  79  74  80  83  14 
HepB3 66  61  77  72  67 
HepB_BD 43  37  32  27 
Hib3 68  36 
MCV 63  69  77  75  86  75 
MCV2 57  68  77  77 
PAB 72  85  85  80  75  70 
PCV3
Pol3 70  70  80  74  83  83  16 
Rota_last 52  31 

Number of districts in the country 135  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
93 
   
/
|
|
\
Greater or equal to 90% 24
From 80 to 89% 16
From 50 to 79% 47
Less than 50% 12
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes <12 months
DT 2, 4, 6, 18 months; 4-6 years; Yes
DTwPHib 4, 18 months; 4-6 yearrs; Yes
DTwPHibHepB 2, 6 months; Yes
HepB birth; Yes and >=Y16
IPV 2, 4, 6, 18 months Yes
MMR 15 months; 4-5 years; Yes
Measles 9 months; Yes
OPV birth; 2, 4, 6, 18 months; 4-6 years; Yes
Pneumo_conj No High risk group
Rotavirus 2, 4, months; Yes
TT 1st contact; +1, +6 months; +1, +1 years; Yes CBAW
Typhoid Yes high risk adults
VitaminA 9 months; 4-6 years
YF No high risk adults

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2017  2012-2017  2012-2017  2010-2014  2009-2014  2010-2114  2009 - 2013 
Nº of districts with microplans that include activities to raise immunization coverage number 135  133    129    72  114 

System performance

Total Nº districts in country number 135  133  130  129  125  121  115 
Nº districts with DTP3 coverage >=80% number 54  68  65  98  73  73  70 
% of districts with DTP3 coverage >=80% From 0 to 100% 40  51  50  76  58  60  61 
Nº districts with measles (MCV1) coverage >=95% number 21  15  23  37  39  50  50 
% of districts with MCV1 coverage >=95% From 0 to 100% 16  11  18  29  31  41  43 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes    Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 90  100        98  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.